G0483 HCPCS code: Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed

G0483 is the HCPCS Level II code for drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed. In 2024 Medicare paid an average of $240.68 per service for G0483 across 540,945 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1 per day on outpatient hospital claims. Medicare volume fell 21% from 2022 to 2024 (688,202 to 540,945 services). In 2024, about 1,720 clinicians billed Medicare for G0483 for 254,588 beneficiaries; California, North Carolina, Texas accounted for 52% of services.

Code details

FieldValue
SectionG codes — Procedures and professional services (temporary)
Coverage codeC — Carrier judgment
Pricing indicator21 — Priced on the Clinical Laboratory Fee Schedule
BETOS categoryT1H
Added2016-01-01
Last action effective2017-01-01

Who bills G0483 (2024)

MeasureValue
Clinicians billing (by place of service)1,720
Medicare beneficiaries254,588
States with claims42
Share of services in top 3 states (California, North Carolina, Texas)52%

Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.

Medicare utilization for G0483, 2022–2024

YearServicesBeneficiariesAvg. allowedAvg. paid
2022688,202313,278$242.55$242.55
2023597,922279,202$240.59$240.59
2024540,945254,588$240.68$240.68

States with the most G0483 services (2024)

StateServicesAvg. paid
California122,717$241.55
North Carolina96,852$239.09
Texas60,504$240.34
Tennessee41,808$240.88
Florida24,773$241.39

NCCI unit limits (MUE)

Claim typeMax units per dayRationale
outpatient hospital claims1Code Descriptor / CPT Instruction
practitioner claims1Code Descriptor / CPT Instruction

Medicare policy articles for this code

Covered diagnoses (1,451 ICD-10-CM codes)

The diagnoses most often listed as covered in the policy articles above:

ICD-10-CMDiagnosisArticles listing it
E87.21Acute metabolic acidosis7
E87.22Chronic metabolic acidosis7
E87.29Other acidosis7
F11.20Opioid dependence, uncomplicated7
F11.220Opioid dependence with intoxication, uncomplicated7
F11.221Opioid dependence with intoxication delirium7
F11.222Opioid dependence with intoxication with perceptual disturbance7
F11.229Opioid dependence with intoxication, unspecified7
F11.23Opioid dependence with withdrawal7
F11.24Opioid dependence with opioid-induced mood disorder7

Showing 10 of 1,451. The full list, non-covered diagnoses and CSV export are in Caduvo.

What changed for G0483

Frequently asked questions

What is HCPCS code G0483?

G0483 is the HCPCS Level II code for drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed. Short descriptor: "Drug test def 22+ classes".

How much does Medicare pay for G0483?

In 2024, the average Medicare payment was $240.68 per service (average allowed $240.68).

Does Medicare cover G0483?

Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.

Which diagnoses support coverage for G0483?

Medicare policy articles that cite G0483 list 1,451 covered ICD-10-CM diagnosis codes across 7 articles. The most cited include E87.21 (Acute metabolic acidosis), E87.22 (Chronic metabolic acidosis), E87.29 (Other acidosis). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.

How many units of G0483 can be billed per day?

1 on outpatient hospital claims; 1 on practitioner claims (NCCI medically unlikely edits).

Related G04 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.

All G codes · HCPCS lookup